US equities
|
MU
$1,035.84
▲+0.00%
SPCX
$160.57
▲+0.00%
NVDA
$230.48
▲+0.00%
SNDK
$1,609.46
▲+0.00%
AAPL
$340.42
▲+0.00%
INTC
$107.08
▲+0.00%
ITGR
$126.65
▲+0.00%
AMD
$620.68
▲+0.00%
MU
$1,035.84
▲+0.00%
SPCX
$160.57
▲+0.00%
NVDA
$230.48
▲+0.00%
SNDK
$1,609.46
▲+0.00%
AAPL
$340.42
▲+0.00%
INTC
$107.08
▲+0.00%
ITGR
$126.65
▲+0.00%
AMD
$620.68
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Medulloblastoma
Recent news which mentions Medulloblastoma
Curtana Pharmaceuticals Signs Development and Manufacturing Agreement with Catalent for Brain Cancer Drug CT-179
July 15, 2021
Tickers
GBM
Tags
United States
Manufacturing
CT/179
From
PRLog